Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Flight cancellations: Full list of 40 airports hit by FAA cuts amid government shutdown - 2Misjudged Objections For Solo Voyagers
- 3Productive CRM Programming for Client Relationship The executives
- 4No respite for German economy as experts slash forecast over Iran war
- 5Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
- The Strait of Hormuz Isn’t Just an Oil Problem, It’s Now a Food Problem
- The Force of Organic product: 10 Assortments That Improve Your Wellbeing
- These men carry towers of birds through Mexico's streets. They say their tradition is dying out.
- Flu season is ramping up, and some experts are "pretty worried"
- Bruno Mars tour 2026: How to get tickets for 'The Romantic Tour,' presale times, prices and more
- Instructions to Boost Your True capacity with a Brain research Degree
- Vote In favor of Your Number one Game Control center
- Hand Skin Is Additionally Significant - What You Ought to Realize About Hand Cream
- Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance
